Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19491| Title: | Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG) |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Aged, 80 and over,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Carcinoma, Non-Small-Cell Lung/*drug therapy/pathology,Deoxycytidine/administration & dosage/adverse effects/*analogs &,derivatives/therapeutic use,Disease-Free Survival,Drug Administration Schedule,Female,Greece,Humans,Lung Neoplasms/*drug therapy/pathology,Male,Middle Aged,Paclitaxel/administration & dosage/adverse effects/*therapeutic use,Vinblastine/administration & dosage/adverse effects/*analogs &,derivatives/therapeutic use |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/19491 |
| ISSN: | 1569-8041 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/20880999 http://annonc.oxfordjournals.org/content/22/4/827.full.pdf |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Kosmidis-2011-Paclitaxel and gemci.pdf | 409.98 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
